Patents by Inventor Pierre Dillard

Pierre Dillard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Co-Expression of Constructs and Polypeptides
    Publication number: 20260193669
    Abstract: The present disclosure relates to vectors, such as DNA plasmids, comprising multiple nucleic acid sequences of interest engineered to be co-expressed as separate molecules, pharmaceutical compositions comprising such vectors and the use of such vectors and such pharmaceutical compositions in the treatment or prevention of diseases or in the prophylactic or therapeutic treatment of autoimmune diseases, allergic diseases and graft rejection.
    Type: Application
    Filed: November 9, 2023
    Publication date: July 9, 2026
    Applicant: Nykode Therapeutics ASA
    Inventors: Audun Trygge Haugen Bersaas, Pierre Dillard, Bruno Douradinha, Lars-Egil Fallang, Stine Granum, Joel Benjamin Heim, Gunnstein Norheim, Monika Sekelja, Flourina Kumar Thakor, Inga Winge, Louise Bjerkan
  • TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS
    Publication number: 20250288654
    Abstract: The present disclosure relates to tolerance-inducing constructs for inducing tolerance, such as by targeting the tolerance-inducing construct to antigen presenting cells (APCs). Further disclosed are polynucleotides, vectors, host cells, pharmaceutical compositions and kits comprising said tolerance-inducing construct. Also disclosed are tolerance-inducing constructs and compositions for use in the treatment of immune disorders, such as in the prophylactic or therapeutic treatment of autoimmune diseases, allergic disease and graft rejection.
    Type: Application
    Filed: May 10, 2022
    Publication date: September 18, 2025
    Applicant: Nykode Therapeutics ASA
    Inventors: Agnete Brunsvik Fredriksen, Heidi Myrset, Audun Trygge Haugen Bersaas, Stine Granum, Pierre Dillard
  • CO-EXPRESSION OF CONSTRUCTS AND IMMUNOSTIMULATORY COMPOUNDS
    Publication number: 20250222085
    Abstract: The present invention relates to vectors, such as DNA plasmids, comprising multiple nucleic acid sequences engineered to be co-expressed as separate molecules. Such separate molecules include a first polypeptide, wherein the first polypeptide comprises a targeting unit that targets antigen-presenting cells, a multimerization unit, such as dimerization unit, and an antigenic unit comprising one or more antigens or parts thereof, and one or more immunostimulatory compounds.
    Type: Application
    Filed: May 10, 2022
    Publication date: July 10, 2025
    Applicant: Nykode Therapeutics ASA
    Inventors: Agnete Brunsvik Fredriksen, Audun Trygge Haugen Bersaas, Stine Granum, Pierre Dillard